# Hypoxia Analysis in Head and/or Neck Cancer

> **NCT02414048** · PHASE2 · UNKNOWN · sponsor: **Marius Gustav Bredell** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Pimonidazole

## Key facts

- **NCT ID:** NCT02414048
- **Lead sponsor:** Marius Gustav Bredell
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2016-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02414048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02414048, "Hypoxia Analysis in Head and/or Neck Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02414048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*